Thanks for subscribing to the podcast

COTA Joins Aetion CARE Initiative

In this episode of Real World Talk, host Sandy Leonard sits down with Ulka Campbell, Head of Scientific Strategy at Aetion, and CK Wang, Chief Medical Officer at COTA. They dive into the Aetion CARE program, a cross-industry initiative aimed at understanding real-world data’s role in evaluating oncology therapeutics.

Laura Fernandes and Sesh Srinivasan on Constructing Effective ECAs

In this episode of Real World Talk, Sandy Leonard from COTA hosts a thought-provoking discussion with Laura Fernandes, Senior Statistical Director at COTA, and Sesh Srinivasan, Product Management Lead at Deloitte. The conversation revolves around the future of real world data and the exploration of external control arms (ECAs) in drug development.

Using Centralized Real-World Data to Improve Patient Outcomes With Marisa Co and David Anstatt

In the world of clinical trials, having a well-defined research question is key. And that’s where fit-for-purpose data sets come in. But what are the factors for defining research questions? In this episode of the Real World Talk podcast, we get to hear from Seshamalini Srinivasan, Karla Feghali, Mandy Kelly, and Laura Fernandes. They talk about the criteria for defining research questions, the importance of fit-for-purpose data, and the other factors to consider in real-world data sources.

Using Fit-for-Purpose Data to Improve Patient Outcomes With Seshamalini Srinivasan, Karla Feghali, Mandy Kelly, Laura Fernandes

How to Handle Potential Biases When Dealing With Real-World Data Featuring Laura Fernandes

Real-world data holds great potential for clinical trials, and it can support clinical development and regulatory decision-making. But when working with data, we need to be conscious of potential biases. In this episode of the Real World Talk podcast, our host Christie Zettler welcomes Laura Fernandes, Senior Statistical Director at COTA. They talk about the JSM conference, AML response validation work, and how to account for potential biases when dealing with RWD.

Learning How Combining RCTs and RWD Helps With Patient Outcomes Featuring Seshamalini Srinivasan, Laura Fernandes, and Karla Feghali

Real world data (RWD) is data that’s collected outside of clinical trials, whereas randomized controlled trials (RCTs) are conducted to measure the effectiveness of a specific medication or treatment. But how can these two work together to improve patient outcomes? In this episode of the Real World Talk podcast, our host Mandy Kelly welcomes Seshamalini Srinivasan, Laura Fernandes, and Karla Feghali to talk about the importance of combining RWD and RCTs to bring life-saving treatments to patients faster.

Thanks for reaching out

COTA Joins Aetion CARE Initiative

Laura Fernandes and Sesh Srinivasan on Constructing Effective ECAs

Using Centralized Real-World Data to Improve Patient Outcomes With Marisa Co and David Anstatt

Using Fit-for-Purpose Data to Improve Patient Outcomes With Seshamalini Srinivasan, Karla Feghali, Mandy Kelly, Laura Fernandes

How to Handle Potential Biases When Dealing With Real-World Data Featuring Laura Fernandes

Learning How Combining RCTs and RWD Helps With Patient Outcomes Featuring Seshamalini Srinivasan, Laura Fernandes, and Karla Feghali

Bringing clarity to cancer

Subscribe for Updates

Receive our latest news and research from thought leaders in the RWD industry